Form 4: Calix CEO Sells 74,000 Shares Under 10b5-1 Plan

Calix President and CEO Michael Weening sold 74,000 shares of common stock for $57 per share after exercising options at $8.03, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Michael Weening, President & CEO and Director of Calix, Inc. (CALX), executed a pre-planned transaction.
• On August 4, 2025, Weening exercised a stock option to acquire 74,000 shares of common stock at an exercise price of $8.03 per share.
• Immediately following the exercise, Weening sold all 74,000 of these shares at a price of $57 per share.
• The transactions were conducted under a Rule 10b5-1 trading plan adopted on February 28, 2025.
• Following these transactions, Weening's direct beneficial ownership of Calix common stock is 15,812 shares.
• The stock option, which was fully vested on February 14, 2023, and set to expire on February 14, 2029, is now fully exercised and no longer held.

Sentiment

Score: 5

Explanation: Neutral to slightly negative. While the sale was pre-planned via a 10b5-1 plan, which mitigates negative perception, it still represents a reduction in direct insider ownership. The significant profit from the option exercise is positive for the executive but does not directly impact company operations or future prospects.

Positives

• The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new negative information.
• The significant difference between the option exercise price ($8.03) and the sale price ($57) indicates a substantial gain for the insider, reflecting past stock appreciation.

Negatives

• The sale of 74,000 shares by the President and CEO represents a reduction in direct insider ownership, which can sometimes be perceived negatively by investors.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May view the insider sale with slight caution, though the 10b5-1 plan mitigates concerns. The executive realized significant value from their equity.

Key Dates

Recommendation

The filing details a pre-planned insider sale by the CEO, which is a routine liquidity event for executives. While a sale reduces insider ownership, the existence of a 10b5-1 plan suggests it is not based on new, negative information. The significant profit realized by the CEO from the option exercise highlights past stock performance. Without additional company-specific news or broader market context, this Form 4 alone does not warrant a change from a 'hold' position, as it is a pre-scheduled transaction rather than a signal of new fundamental insights.

Keywords

Calix, CALX, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Michael Weening, 10b5-1 Plan, Corporate Governance, Executive Compensation